Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Atyr Pharma: Q2 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.3 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of 11 cents. In the final minutes of…
NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ)
Shares of NRx Pharmaceuticals (NRXP) rose on Friday after the company announced that the FDA didn't identify any major deficiencies as part of an initial review of its marketing application for its preservative-free ketamine product. The regulator…
USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
The officials of the Drug Control Administration (DCA) in Andhra Pradesh and U.S. Food and Drug Administration (USFDA) discussed ways to strengthen global regulatory collaboration and promote scientific pharmaceutical manufacturing at the…
Rinn Pharma & Biopharma to join NordicPharmaTrain network
The partnership will significantly strengthen Ireland's position within the European pharmaceutical research and innovation space. Research Ireland's Rinn Pharma & Biopharma, which is Ireland's national centre for research and innovation in the…
Medical device start-ups finding it challenging to sell their products, need industry partnerships to survive: Pharma Secretary Manoj Joshi
Calling India's medical device start-up ecosystem vibrant but commercially fragile, Pharma Secretary Manoj Joshi on Friday said many start-ups are struggling to take their innovations to market despite receiving government support, and urged…
Wise Equity inks agreement to acquire E-Pharma Trento
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Royalty Pharma (NASDAQ:RPRX) Lowered to 'Buy' Rating by Wall Street Zen
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was downgraded by Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a note issued to investors on Saturday. How Royalty Pharma Prints Cash Without Biotech's Biggest Risks RPRX has been…
Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Investment analysts at HC Wainwright upped their Q3 2027 earnings estimates for Urogen Pharma in a research note issued to investors on Thursday…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $16.85, but opened at $18.49. Ascentage Pharma Group International shares last traded at…
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its price target upped by stock analysts at JPMorgan Chase & Co. from $58.00 to $62.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an 'overweight' rating…
Q1 Results 08th Aug Live: Delhivery, Anant Raj, Apollo Micro Systems, Akums Drugs Pharma, Aditya Birla Fashion, Ceigall India, PNC Infratech Oswal Pumps to announce Q1 results
Q1 Results Today, 08th August 2026 Live Updates: Find all the latest Q1 results 2026 updates of Aditya Birla Fashion and Retail, Akums Drugs and Pharmaceuticals, Anant Raj, Anmol India, Apollo Micro Systems, Delhivery, Eveready Industries India…
Aptar (ATR) Q2 2026 Earnings Call Transcript
Friday, July 31, 2026 at 9:00 a.m. ET President and CEO - Stephan Tanda Executive Vice President and CFO - Vanessa Kanu CEO Designate and President of Aptar Pharma - Gael Touya Senior Vice President, Investor Relations and Communications - Mary…
Ziff Davis expects Q3 revenue down low- to mid-single digits as AI-authored code targets nearly all by end of 2026 (NASDAQ:ZD)
Proceeds will fund tax payments (about $200 million), repay $149 million convertible debt, support ongoing share buybacks, and may be used for potential M&A opportunities. Key risks include declining search referral traffic, increased use of…
Equities Analysts Offer Predictions for NAMS FY2027 Earnings
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - Equities research analysts at HC Wainwright lowered their FY2027 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research note issued to investors on Thursday…
Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript
Friday, Jul. 31, 2026 at 7:30 a.m. ET Head of Investor Relations - Adam Uhlman Chief Executive Officer - Patrick Kaltenbach Chief Financial Officer - Shawn Vadala Net Sales -- $1.027 billion, representing a 4% increase on a reported basis or 6% in…
Receive a Daily briefing on Pharma Industry News
Get Started